about
Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)Premature ovarian failureMother's menopausal age is associated with her daughter's early follicular phase urinary follicle-stimulating hormone levelExpansion of the fragile X CGG repeat in females with premutation or intermediate allelesLearning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.Unstable mutations in the FMR1 gene and the phenotypesRepeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disordersStudy of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 GeneMolecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related DisordersMolecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targetsLongitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.The role of AGG interruptions in the transcription of FMR1 premutation allelesAttitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserveAMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat levelElevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserveLevels and associations among self-esteem, fertility distress, coping, and reaction to potentially being a genetic carrier in women with diminished ovarian reserve.Consensus characterization of 16 FMR1 reference materials: a consortium studyX-linked mental retardation (XLMR): from clinical conditions to cloned genes.Ovarian dysfunction and FMR1 alleles in a large Italian family with POF and FRAXA disorders: case reportMethylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study.Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome.RNA-binding proteins in human oogenesis: Balancing differentiation and self-renewal in the female fetal germlineFour decades of leading-edge research in the reproductive and developmental sciences: the Infant Primate Research Laboratory at the University of Washington National Primate Research Center.Pathogenesis and causes of premature ovarian failure: an update.Gender and cell-type-specific effects of the transcription-coupled repair protein, ERCC6/CSB, on repeat expansion in a mouse model of the fragile X-related disordersA Variance-Component Framework for Pedigree Analysis of Continuous and Categorical Outcomes.Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome.Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion.Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study.X inactivation plays a major role in the gender bias in somatic expansion in a mouse model of the fragile X-related disorders: implications for the mechanism of repeat expansion.Cis-acting DNA sequence at a replication origin promotes repeat expansion to fragile X full mutation.Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency.Ovarian aging and premature ovarian failure.Five mutations of mitochondrial DNA polymerase-gamma (POLG) are not a prevalent etiology for spontaneous 46,XX primary ovarian insufficiencyFMR1 and the fragile X syndrome: human genome epidemiology reviewFragile X mental retardation protein in plasticity and disease.Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project.Fragile X syndrome: diagnostic and carrier testing.
P2860
Q21198724-AA7C77BB-2061-481E-99B8-9CAFE925C476Q21203021-DBC603A1-1AF1-4808-875C-10097D886598Q23910017-737B1C27-1B6B-4731-8585-91D48CB355AAQ24610645-061DC935-772F-439C-A89B-82E71EB0BDB8Q26866506-CB3DE35A-36F0-4030-9CBE-CACC1B02D7C2Q26996649-7B957A79-D016-42C0-BE13-C5C46E129CA4Q27011565-C57B4932-ECBA-47E3-B4F3-BF46A4C8F301Q28077015-5C107D6C-0054-4E69-A7B0-9A98BCD3FBF6Q28077980-33F05099-EB58-480B-93D2-625AD0D79516Q28583305-8742BF8F-AAF7-437D-934C-860F8EE5F81DQ28672679-BE37E8F2-D491-4657-A3AB-A165B15301D2Q28742438-CBE6DF78-5046-46D5-A106-548529872FB5Q30354458-7DBB8863-401B-4408-A98D-687D343B061FQ30370644-CDDF5FB2-B301-4C64-A75A-4DF25E3329B5Q30412537-983F21EC-0ED9-46AD-B99C-4DC845741E54Q30412762-542F3D33-C075-473C-95ED-FF84CC9B5E16Q30440559-09900B02-C9CD-490D-9C42-A3BBC4C66B25Q33205129-AE6431B6-48B0-425B-A4E8-A59A0270720FQ33281822-0C62B644-BD66-41B9-B54D-470C75ED33C1Q33527737-3A695304-D296-4791-BFCA-B914F08DA31CQ33617701-1FECC82F-8E75-48F8-A210-B1D3E7757F0DQ33650175-C65DB14B-51B5-4E6F-91A0-BABB20B4CD4FQ33732476-E6D9D824-9F29-4892-BCC0-4E99AB3CFFE8Q33750568-E2AB977F-710C-48EC-9E28-4125F46ED690Q33764453-F6B43A36-183E-4256-904C-C383FB1BE86EQ33794136-8A3D8812-E9CD-492F-B748-2038F61ECD1EQ33812475-A5D1F40A-CAE6-4F16-950A-3AB9F4C5D655Q33897004-C69F517B-84D0-41C4-8F26-DD30D6ED4DA8Q33901895-1DA172C5-25A5-4B88-88C9-D56501FC804EQ33969311-5FF2E420-87D7-4CCC-9C33-93C5DBDD7875Q34013270-86E38412-E6E8-4E73-9C38-86567C57ADECQ34074533-FC6B059E-CBE6-44A9-861B-E942E75308B4Q34117236-BCC6A8D8-29A2-4656-ADE0-8D7D9C46B422Q34148608-26CBD29E-2FFA-4177-AFE9-A9890F1C405DQ34330442-C51A6E78-2ABB-4ED3-B11C-32E192CEAFE6Q34354181-0573EFEA-7A85-44C7-882A-939F2C3DE89AQ34362009-C629638C-0631-4647-883D-21A131FCE8B5Q34993137-D794DD39-CDE9-4F4E-B6FB-4862D44D12B0Q35010754-D08BAC20-3E9C-40CF-8E87-719C4EB895C0Q35033858-B2FB4480-7A42-4335-9E71-455AFA272002
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Premature ovarian failure in the fragile X syndrome.
@ast
Premature ovarian failure in the fragile X syndrome.
@en
Premature ovarian failure in the fragile X syndrome.
@nl
type
label
Premature ovarian failure in the fragile X syndrome.
@ast
Premature ovarian failure in the fragile X syndrome.
@en
Premature ovarian failure in the fragile X syndrome.
@nl
prefLabel
Premature ovarian failure in the fragile X syndrome.
@ast
Premature ovarian failure in the fragile X syndrome.
@en
Premature ovarian failure in the fragile X syndrome.
@nl
P2860
P1476
Premature ovarian failure in the fragile X syndrome.
@en
P2093
Sherman SL
P2860
P304
P356
10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J
P577
2000-01-01T00:00:00Z